Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

GLP-1 drugs show promise in diabetes management, offering heart and kidney benefits, but also highlight the need for ...

Compounded GLP-1 drugs prescribed during previous shortages continue to be another issue, Jaworski said. Even if they came from a licensed pharmacy, these mixtures are often not approved for safety ...

So insurers are capping expenses by erecting a variety of hurdles before covering a GLP-1 drug for obesity ... which analyzes the cost-effectiveness of prescription drugs, said in an April ...

We’re also seeing continued variation in how plans perceive GLP-1s for obesity, whether as lifestyle drugs or as treatments for a chronic disease. As the GLP-1 landscape rapidly evolves with ...

That's the surprising promise emerging from a new study on GLP-1 drugs, drugs already drawing ... and tirzepatide (Zepbound), have greater efficacy in weight loss and metabolic control, although ...

Although semaglutide (Ozempic, Wegovy) and other GLP-1 drugs have rapidly become infamous ... This may be the key to its remarkable efficacy. At its highest doses, tirzepatide causes considerably ...

Compounded GLP-1 RAs ... and Drug Administration (FDA)-approved products. This increasing reliance on compounded versions has prompted concerns regarding safety, consistency, and efficacy ...

People who use GLP-1 injections typically start with low doses of the medication and gradually scale up. Compounded versions of the drugs don’t always follow the same standards for efficacy and ...